GBA1 and Parkinson disease: It has been estimated that 7–10% of PD patients harbor GBA1 mutations [2,5], these patients facing a slight earlier disease onset together with a more aggressive disease course, including a faster progression to dementia, a higher prevalence of neuropsychiatric symptoms, autonomic dysfunction and increased risk of mortality [6].